11-Deoxycortisol impedes GABAergic neurotransmission and induces drug-resistant status epilepticus in mice.
about
Effects of the pattern of glucocorticoid replacement on neural processing, emotional reactivity and well-being in healthy male individuals: study protocol for a randomised controlled trial.Role of hormones and neurosteroids in epileptogenesis.Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability.Rapid comparison of metabolites in humans and rats of different sexes using untargeted UPLC-TOFMS and an in-house software platform.Altered balance between excitatory and inhibitory inputs onto CA1 pyramidal neurons from SV2A-deficient but not SV2B-deficient mice.
P2860
11-Deoxycortisol impedes GABAergic neurotransmission and induces drug-resistant status epilepticus in mice.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
11-Deoxycortisol impedes GABAe ...... nt status epilepticus in mice.
@ast
11-Deoxycortisol impedes GABAe ...... nt status epilepticus in mice.
@en
11-Deoxycortisol impedes GABAe ...... nt status epilepticus in mice.
@nl
type
label
11-Deoxycortisol impedes GABAe ...... nt status epilepticus in mice.
@ast
11-Deoxycortisol impedes GABAe ...... nt status epilepticus in mice.
@en
11-Deoxycortisol impedes GABAe ...... nt status epilepticus in mice.
@nl
prefLabel
11-Deoxycortisol impedes GABAe ...... nt status epilepticus in mice.
@ast
11-Deoxycortisol impedes GABAe ...... nt status epilepticus in mice.
@en
11-Deoxycortisol impedes GABAe ...... nt status epilepticus in mice.
@nl
P2093
P2860
P1433
P1476
11-Deoxycortisol impedes GABAe ...... ant status epilepticus in mice
@en
P2093
Karine Leclercq
Kumar Venkatesan
Manuela Mazzuferi
Rafal M Kaminski
Vincent Seutin
Zhanyan Fu
P2860
P304
P356
10.1016/J.NEUROPHARM.2010.09.021
P577
2010-09-29T00:00:00Z